Cutler Group’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1
| Closed | – | – | 1064 |
|
|
2023
Q4 | $0 | Sell |
1
-46
| -98% | – | ﹤0.01% | 1430 |
|
|
2023
Q3 | $0 | Hold |
47
| – | – | ﹤0.01% | 1515 |
|
|
2023
Q2 | $1K | Sell |
47
-155
| -77% | -$3.3K | ﹤0.01% | 1281 |
|
|
2023
Q1 | $5K | Sell |
202
-16
| -7% | -$396 | ﹤0.01% | 1123 |
|
|
2022
Q4 | $4K | Hold |
218
| – | – | ﹤0.01% | 1453 |
|
|
2022
Q3 | $6K | Buy |
218
+202
| +1,263% | +$5.56K | ﹤0.01% | 1488 |
|
|
2022
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 1987 |
|
|
2022
Q1 | $0 | Sell |
16
-329
| -95% | – | ﹤0.01% | 2070 |
|
|
2021
Q4 | $13K | Buy |
345
+21
| +6% | +$791 | ﹤0.01% | 1596 |
|
|
2021
Q3 | $16K | Buy |
324
+296
| +1,057% | +$14.6K | ﹤0.01% | 1588 |
|
|
2021
Q2 | $2K | Buy |
+28
| New | +$2K | ﹤0.01% | 1954 |
|